Tabernero J, Van Cutsem E, Bang Y-J, Fuchs CS, Wyrwicz L, Lee KW, Kubada I, Garrido M, Chung HC, Salguero HRC, Mansoor W, Braghiroli MIFM, et al. Pembrolizumab with or without chemotherapy versus chemotherapy for advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The phase III KEYNOTE-062 study. Journal of Clinical Oncology. 2019 Jun 20;37(18_suppl):LBA4007–7.